Description
GLP-1 Peptide
Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist of the GIP and GLP-1 receptors, studied in metabolic research for its role in insulin secretion, appetite regulation, and gastric-emptying signaling. A fatty diacid side chain extends its research half-life, supporting less-frequent dosing protocols.
Specifications
| CAS Number | 2023788-19-2 |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813.45 g/mol |
| Available Strengths | 10mg · 15mg · 50mg · 100mg |
| Purity | ≥99% (HPLC verified) |
| Storage | -20°C lyophilized, protected from light and moisture; 2-8°C after reconstitution |
✓ Certificate of Analysis available for this production lot — view our testing process
In the Lab
Tirzepatide hits both the GIP and GLP-1 receptors, and that dual action is the whole story — it’s why metabolic researchers moved past single-receptor compounds in the first place. The attached fatty acid chain also means it sticks around longer, so studies don’t need constant re-dosing to see what’s happening.
Reviews
There are no reviews yet.